Clinical trials
Observational Hepatitis C, Chronic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2005 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Terminated | 4 |
| Withdrawn | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 4 |
| Hoffmann-La Roche | 3 |
| University of North Carolina, Chapel Hill | 3 |
| Gilead Sciences | 2 |
| Johns Hopkins University | 2 |
| University of California, San Diego | 2 |
| Avera McKennan Hospital & University Health Center | 1 |
| Duke University | 1 |
| George Washington University | 1 |
| Mayo Clinic | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C, Chronic | 30 |
| Hepatitis C | 18 |
| Acquired Immunodeficiency Syndrome | 6 |
| Liver Diseases | 4 |
| HIV Infections | 3 |
| Fibrosis | 2 |
| Hepatitis | 2 |
| Hepatitis B, Chronic | 2 |
| Atherosclerosis | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.